U.S. federal trademark · Serial No. 77397328 · Reg. No. 203345
Medicinal preparations, pharmaceutical preparations and/or biochemical preparations, namely, viral or non-viral vectors to be used in gene delivery, gene transfer, gene regulation and gene modulation, all for the treatment and prevention of angiogenesis-related diseases and conditions such as cancer, metastatic disease, ischemia, auto-immune diseases, vascular disorders, disorders arising from improper vascularization, ophthalmologic diseases and diagnostic imaging; pharmaceutical substances and preparations, namely, genetically engineered promoters and enhancers for the treatment of angiogenesis-related diseases and conditions such as cancer, metastatic disease, ischemia, auto-immune diseases, vascular disorders, disorders arising from improper vascularization, ophthalmologic diseases and diagnostic imaging; diagnostic preparations for medical use; pharmaceutical and biochemical preparations for the treatment of angiogenesis-related diseases
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.